BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6102022)

  • 1. Prevention of sudden death in acute myocardial ischaemia.
    Fejfar Z; Vrána M; Horák O; Trcka V; Kristan L; Blazek Z; Korál V; Sychra T
    Czech Med; 1980; 3(1):28-35. PubMed ID: 6102022
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy of sudden cardiac death due to acute myocardial ischaemia. Experimental and clinical experience.
    Szekeres L
    Cor Vasa; 1986; 28(2):123-37. PubMed ID: 3524989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimepranol, a Czechoslovak-made beta blocker, in the treatment of acute myocardial infarction.
    Charvát J; Pavlovic J; Fiserová J
    Acta Univ Carol Med (Praha); 1984; 30(1-2):117-23. PubMed ID: 6150627
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic effects and tolerance for trimepranol in acute myocardial infarct].
    Pavlovic J; Charvát J; Fiserová J
    Vnitr Lek; 1982 Dec; 28(12):1191-7. PubMed ID: 6130651
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of diltiazem upon experimental ventricular dysrhythmias.
    Patterson E; Eller BT; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and metabolic effects of metipranolol].
    Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F
    Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sudden death in acute myocardial infarct and problems of resuscitation].
    Ganelina IE
    Klin Med (Mosk); 1969 Nov; 47(11):112-9. PubMed ID: 5380018
    [No Abstract]   [Full Text] [Related]  

  • 9. The early phase of acute myocardial infarction: pharmacologic aspects of therapy.
    Ann Intern Med; 1973 Jun; 78(6):918-36. PubMed ID: 4197372
    [No Abstract]   [Full Text] [Related]  

  • 10. An experimental contribution to the treatment of acute myocardial infarction.
    Vrána M; Hess L; Vránová Z; Fejfar Z
    Czech Med; 1987; 10(3):142-55. PubMed ID: 2889585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of sulfinpyrazone on early ventricular fibrillation and 2d-phase arrhythmias in acute myocardial infarction (author's transl)].
    Gülker H; Bender F; Thale J; Heuer H; Kristek J; Dorsel T; Pierchalla P
    Z Kardiol; 1980 Nov; 69(11):751-6. PubMed ID: 7467658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of sudden coronary death.
    Fejfar Z; Vrána M; Hess L; Vránová Z; Blazek Z
    Czech Med; 1991; 14(1):22-34. PubMed ID: 1676965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular premature beats and sudden death.
    N Engl J Med; 1978 Mar; 298(9):512-3. PubMed ID: 74801
    [No Abstract]   [Full Text] [Related]  

  • 14. The search for the position of the signal-averaged electrocardiogram in risk stratification after acute myocardial infarction.
    Cinca J; Soler-Soler J
    Eur Heart J; 1998 Apr; 19(4):537-8. PubMed ID: 9597399
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ventricular fibrillation as a cause of sudden death in pre-hospitalization period during myocardial infarct].
    Caturelli G; Visentin M
    Cardiol Prat; 1973; 24(4):381-5. PubMed ID: 4789868
    [No Abstract]   [Full Text] [Related]  

  • 16. Antifibrillatory actions of nadolol.
    Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1982 Oct; 223(1):144-52. PubMed ID: 6126580
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of adrenaline-induced metabolic systemic and myocardial alterations by the beta-blocking agent metipranolol in the dog.
    Herbaczyńska-Cedro K; Woźniewicz B; Broniszewska-Ardelt B; Ceremuzyński L
    Cardiology; 1981; 67(4):206-18. PubMed ID: 6113891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Norwegian Multicenter Study on timolol after myocardial infarction. Part II. Effect in different risk groups, causes of death, heart arrest, reinfarctions, rehospitalizations and adverse experiences.
    Lund-Johansen P
    Acta Med Scand Suppl; 1981; 651():243-52. PubMed ID: 7034476
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of antiarrhythmics in the post-infarction period].
    Dinanian S
    Arch Mal Coeur Vaiss; 2000 Apr; 93(3 Spec No):65-9. PubMed ID: 10816803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment, significance and mechanism of ventricular electrical instability after myocardial infarction.
    Richards DA; Denniss AR
    Heart Lung Circ; 2007 Jun; 16(3):149-55. PubMed ID: 17446130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.